The use of fluconazole in the treatment of superficial fungal infections- A meta-analysis
暂无分享,去创建一个
[1] S. Dogra,et al. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India) , 2018, BMC Dermatology.
[2] T. Einarson,et al. An Overview of Topical Antifungal Therapy in Dermatomycoses , 1998, Drugs.
[3] G. Garber. An Overview of Fungal Infections , 2012, Drugs.
[4] D. Denning,et al. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? , 2006, The Journal of antimicrobial chemotherapy.
[5] P. Fidel. History and new insights into host defense against vaginal candidiasis. , 2004, Trends in microbiology.
[6] B. Elewski,et al. Guidelines of care for superficial mycotic infectionsof the skin: Tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis , 1996 .
[7] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[8] T. Zimmermann,et al. Bioavailability of fluconazole in the skin after oral medication , 1994, Mycoses.
[9] J. Faergemann,et al. Levels of fluconazole in serum, stratum corneum, epidermis‐dermis (without stratum corneum) and eccrine sweat , 1993, Clinical and experimental dermatology.
[10] R. Mertens,et al. Skin and Nail Mycoses: Treatment with Ketoconazole, a New Oral Antimycotic Agent: Haut‐ und Nagelmykosen: Behandlung mit Ketoconazole, einem neuen oralen Antimykotikum , 1979, Mykosen.
[11] Dillwyn Williams,et al. Oral treatment of ringworm with griseofulvin. , 1958, Lancet.